Structure Therapeutics to Participate in the Jefferies Global Healthcare Conference
Globe Newswire•04/11/2026•07:30 ET
0
Key Highlights
- ➤Structure Therapeutics will participate in Jefferies Global Healthcare Conference November 16-19, 2026
- ➤Management fireside chat scheduled November 17 at 12:00 PM GMT in London
- ➤Structure Therapeutics develops oral small-molecule treatments for chronic metabolic diseases
- ➤Pipeline features multiple wholly owned clinical-stage oral small-molecule compounds targeting GPCRs
SAN FRANCISCO, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, with a focus on chronic weight management, today announced that management will participate in the Jefferies Global Healthcare Conference being held November 16-19, 2026 in London, UK.
Jefferies Global Healthcare Conference Date: Tuesday, November 17 Format: Fireside chat and 1x1 meetings Time: 12:00 PM GMT Location: London, UK
Get started
Create a free account to read the full story.